Graft-versus-host disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
(2 intermediate revisions by one other user not shown)
Line 5: Line 5:


{{SK}} GVHD
{{SK}} GVHD
==[[Graft-versus-host disease patient information|Patient Information]]==


==[[Graft-versus-host disease overview|Overview]]==
==[[Graft-versus-host disease overview|Overview]]==
Graft-versus-host disease (GvHD) is a condition characterized by recipient tissue damage that arise from immunological activation of donor T lymphocytes. It typically occurs in the setting of bone marrow transplantation. Donor T cells mount a response against foreign host cells in the gastrointestinal system, liver, and skin.


==[[Graft-versus-host disease historical perspective|Historical Perspective]]==
==[[Graft-versus-host disease historical perspective|Historical Perspective]]==
Line 28: Line 29:


==Diagnosis==
==Diagnosis==
 
[[Graft-versus-host disease diagnostic study of choice|Diagnostic Study of Choice]]
[[Graft-versus-host disease history and symptoms|History and Symptoms]]
| [[Graft-versus-host disease history and symptoms|History and Symptoms]]
| [[Graft-versus-host disease physical examination|Physical Examination]]
| [[Graft-versus-host disease physical examination|Physical Examination]]
| [[Graft-versus-host disease laboratory findings|Laboratory Findings]]
| [[Graft-versus-host disease laboratory findings|Laboratory Findings]]
| [[Graft-versus-host disease electrocardiogram|Electrocardiogram]]
| [[Graft-versus-host disease chest x ray|Chest X Ray]]
| [[Graft-versus-host disease chest x ray|Chest X Ray]]
| [[Graft-versus-host disease echocardiograph and ultrasound|Echocardiograph and Ultrasound]]
| [[Graft-versus-host disease CT|CT]]
| [[Graft-versus-host disease CT|CT]]
| [[Graft-versus-host disease mri|MRI]]
| [[Graft-versus-host disease other imaging findings|Other Imaging Findings]]
| [[Graft-versus-host disease other imaging findings|Other Imaging Findings]]
| [[Graft-versus-host disease other diagnostic studies|Other Diagnostic Studies]]
| [[Graft-versus-host disease other diagnostic studies|Other Diagnostic Studies]]
Line 39: Line 43:
==Treatment==
==Treatment==
| [[Graft-versus-host disease medical therapy|Medical Therapy]]
| [[Graft-versus-host disease medical therapy|Medical Therapy]]
| [[Graft-versus-host disease surgery|Surgery]]
| [[Graft-versus-host disease primary prevention|Primary Prevention]]
| [[Graft-versus-host disease primary prevention|Primary Prevention]]
| [[Graft-versus-host disease secondary prevention|Secondary Prevention]]
| [[Graft-versus-host disease secondary prevention|Secondary Prevention]]
| [[Graft-versus-host disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
| [[Graft-versus-host disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
| [[Graft-versus-host disease future or investigational therapies|Future or Investigational Therapies]]
| [[Graft-versus-host disease future or investigational therapies|Future or Investigational Therapies]]
The treatment of GvHD focuses on immunosuppression. Immunosuppression is usually achieved by administering steroids, auch as prednisone or methylprednisolone. Alternative agents include immunophilins like cyclosporine or tacrolimus. Ruxolitinib has been used for GvHD that is refractory to steroids.


==Case Studies==
==Case Studies==

Revision as of 19:03, 2 August 2018

Graft-versus-host disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graft-versus-host disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graft-versus-host disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graft-versus-host disease

CDC on Graft-versus-host disease

Graft-versus-host disease in the news

Blogs on Graft-versus-host disease

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Graft-versus-host disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Synonyms and keywords: GVHD

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiograph and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

| Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters